EcoDrugPlus

Activin A Receptor Type 2b

Ensembl ID : ENSTRUG00000004161
Gene Symbol: ACVR2B
4 Cross references
195 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSTRUG00000005994
Gene Symbol: ADORA1
3 Cross references
204 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSTRUG00000031429
Gene Symbol: ADORA2A
3 Cross references
198 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSTRUG00000029459
Gene Symbol: ADORA2A
3 Cross references
189 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSTRUG00000022664
Gene Symbol: ADORA2B
4 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSTRUG00000030891
Gene Symbol: ADORA3
2 Cross references
143 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSTRUG00000028904
Gene Symbol: ADA
1 Cross references
213 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSTRUG00000030206
Gene Symbol: ADA
1 Cross references
213 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSTRUG00000027623
Gene Symbol: ADA
1 Cross references
213 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSTRUG00000031517
Gene Symbol: ADA
1 Cross references
213 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSTRUG00000016343
Gene Symbol: LOC101071030
3 Cross references
173 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSTRUG00000008130
Gene Symbol: ADRA1B
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).